- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06812520
Educational Intervention to Promote Compression Therapy in People with Venous Ulcer
Educational Intervention to Promote Compression Therapy in People with Venous Ulcer: Pilot and Non-randomized Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Type of study design A feasibility study will be carried out. For this purpose, a study will be carried out without a control group with a pre- and post-test comparison, since it corresponds to phase I of development of an intervention study.
Study hypotheses.
- Users who have a venous ulcer and compression therapy, after the educational intervention, have a smaller area of ulceration than at the beginning of the intervention.
- 50% of users who present venous ulcer and compression therapy show adherence to therapy after the educational intervention.
- Users who have a venous ulcer and compression therapy, after the educational intervention, have a lower intensity of pain than at the beginning of the intervention.
- Users who present with venous ulcer and compression therapy evaluate the acceptability of an educational intervention with a score greater than 2.
who can participate? People over 20 years of age who have a venous ulcer, registered in the commune of Hualpen who meet the inclusion and exclusion criterio.
What are possible risks and benefits of participating? The main risk is presenting some psychoemotional alteration due to possible experiences and experiences or simply not wanting to continue, which would constitute a sufficient reason to suspend the interview, and if psychoemotional symptoms are presented, crisis care will be provided and then referred to the health Center, for your attention and which would constitute sufficient reason to suspend the interview.
The benefits of participation involve all those that are associated with ulcer healing: decrease or closure of the ulcer, decrease in pain, decrease in wound exudate, increase in control of symptoms and signs of venous ulcer, less quantity of cures, improve quality of life, greater mobility.
Patient recruitment will be carried out for convenience; the number of participants to be entered is 22, which was calculated with an estimated loss of 20%.
Recruitment of users will begin in December and is estimated to take place over 2 to 3 months.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ingrid X Briones, candidate for master's degree
- Phone Number: +56973383473
- Email: ingrid.ximena.briones@gmail.com
Study Contact Backup
- Name: Alide A Salazar, doctor
- Phone Number: 56412207065
- Email: alisalaz@udec.cl
Study Locations
-
-
Biobio
-
Hualpen, Biobio, Chile, 4601645
- Recruiting
- Departamento de Salud de la comuna de Hualpen
-
Contact:
- Claudia A Castell, Director
- Phone Number: 56412419957
- Email: ccastell@hualpenciudad.cl
-
Contact:
- Carolina Navarrete, nurse
- Phone Number: 56412426787
- Email: cnavarrete@hualpenciudad.cl
-
Contact:
- Ingrid X Briones L, candidate for master's degree
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult with a grade 2 venous ulcer who is admitted to compression treatment
- Alphabet.
- Management of the Spanish language
Exclusion Criteria:
- Adult who presents a grade 1 venous ulcer
- Adult who presents cognitive impairment (determined by review of clinical record by treating nurse)
- Diagnoses of: dementia,
- Diagnoses Alzheimer's disease
- mental retardation or cognitive deficit
- Adult with severe dependency (determined by review of clinical record by treating nurse) Adult with venous ulcer with cancer undergoing chemotherapy (determined by review of clinical record by treating nurse.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Educational intervention group for adherence
The study only has the intervention group who will receive the educational activity to improve adherence to compression therapy.
|
An educational intervention of 4 face-to-face sessions will be carried out as a complement to the care provided by professionals to users with venous ulcers, which consists of the advanced healing procedure that includes compressive bandaging of the venous ulcer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to compression therapy
Time Frame: 12 weeks
|
Adherence can be defined as the degree to which patients follow the instructions given to them by different professionals.
In this study, adherence to compression therapy will be assessed on each occasion that they attend visits and those who have a percentage of adherence to therapy equal to or above 75% in the 12-week period will be categorized as adherent.
|
12 weeks
|
|
area of ulceration
Time Frame: 12 weeks
|
Surface of the wound that is open, the evaluation is carried out by measuring in centimeters the length at its greatest and width at its largest ends and then multiplying both, with this the ulceration area is obtained.
|
12 weeks
|
|
Acceptability assessment will be carried out by applying the TAP scale
Time Frame: 12 weeks
|
Acceptability will be measured through the Questionnaire developed by Sidani "Treatment Acceptability and Preference" (TAP) adapted to Chilean Spanish. A total scale score is computed as the mean of the four items' scores to reflect level of perceived treatment acceptability. The possible range for the total scale score is 0 to 4, with high score reflecting high acceptability |
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Alide A Salazar, Doctor, Universidad de Concepcion
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEBB1659-2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.